Document is current
Any future updates will be listed below
-
Authors
Muslu, Özlem
Bukur, Thomas
Riesgo-Ferreiro, Pablo
Kher, Sameesh
Akbarinejad, Shaya
Kress, Luis
Gangi Maurici, Stefania
Asim, Muhammad Nabeel
Henrich, Alina
Ahmed, Sheraz
Dengel, Andreas
Löwer, Martin
Ibn-Salem, Jonas
Sahin, Ugur
-
Funding
Funding for this research was provided by:
TRON – Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH
- License Information
-
More Information
Article History
Received: 14 August 2025
Accepted: 19 May 2026
First Online: 19 June 2026
Declarations
:
: Not applicable.
: Not applicable.
: U.S. is co-founder, chief executive officer and stock owner of BioNTech SE. The remaining authors declare no competing interests.
